Joyce Taylor‐Papadimitriou

Author

Also Known As

J J Taylor-Papadimitriou, J TAYLORPAPADIMITRIOU, J Taylor-Papadimitriou, J. TAYLOR-PAPADIMITRIOU, J. TAYLOR‐PAPADIMITRIOU, J. Taylor-Papadimitriou, J. Taylor‐Papadimitriou, JOYCE TAYLOR-PAPADIMITRIOU, JOYCE TAYLOR‐PAPADIMITRIOU, Joyce TAYLOR-PAPADIMITRIOU

357

Publications

22.5K

Citations

H-Index

147

Concepts

All Affiliations

The Honourable Society of Lincoln's Inn Guy's Hospital Breast Cancer Now King's College London Cancer Research UK

About

Joyce Taylor‐Papadimitriou is an author at The Honourable Society of Lincoln's Inn specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	56	112	12.5K
2	Health Sciences	8	8	309
3	Natural Sciences	8	8	1.5K
4	Engineering	4	4	283
5	Public Health	1	1	17

Joyce Taylor‐Papadimitriou

190

Publications

20.3K

Citations

H-Index

Page 1

	Year	Citations
Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin. Sandra Gendler, Carole A. Lancaster, Joyce Taylor‐Papadimitriou, Journal of Biological Chemistry ImmunologyPathologyCancer BiologyMammary Gland DevelopmentTumor Biology	1990	986
Monoclonal antibodies to epithelium‐specific components of the human milk fat globule membrane: Production and reaction with cells in culture Joyce Taylor‐Papadimitriou, Jerry A. Peterson, J. Arklie, International Journal of Cancer Breast OncologyImmunologyPathologyImmunotherapyHuman Lactation	1981	604
A highly immunogenic region of a human polymorphic epithelial mucin expressed by carcinomas is made up of tandem repeats. Sandra Gendler, Joyce Taylor‐Papadimitriou, Trevor Duhig, Journal of Biological Chemistry ImmunologyPathologyImmunotherapyCancer BiologyTumor Biology	1988	573
PLU-1 Is an H3K4 Demethylase Involved in Transcriptional Repression and Breast Cancer Cell Proliferation Kenichi Yamane, Keisuke Tateishi, Robert J. Klose, Molecular Cell ChromatinTranscriptional RegulationMedicineNatural SciencesTranscription Regulation	2007	479
Development and characterization of breast cancer reactive monoclonal antibodies directed to the core protein of the human milk mucin. Joy Burchell, Sandra Gendler, Joyce Taylor‐Papadimitriou, PubMed Breast OncologyImmunocytochemical TechniqueImmunologyPathologyAntigen Processing	1987	478
TARGETING OF IODINE-123-LABELLED TUMOUR-ASSOCIATED MONOCLONAL ANTIBODIES TO OVARIAN, BREAST, AND GASTROINTESTINAL TUMOURS A. A. Epenetos, S. J. Mather, M. Granowska, The Lancet Breast OncologyMedicineImmunologyPathologyBreast Cancer	1982	399
The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9 Richard Beatson, Virginia Tajadura‐Ortega, Daniela Achkova, Nature Immunology Tumor BiologyCancer ImmunosurveillanceOncogenic AgentMedicineImmunology	2016	376
Comparison of O-Linked Carbohydrate Chains in MUC-1 Mucin from Normal Breast Epithelial Cell Lines and Breast Carcinoma Cell Lines: Kenneth O. Lloyd, Joy Burchell, Valery Kudryashov, Journal of Biological Chemistry	1996	360
Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells. Keith R. Jerome, Donna L. Barnd, Katharine M. Bendt, PubMed Mucin Protein CoreCancer ImmunosurveillanceMedicineBreast AdenocarcinomaEpitope Present	1991	353
Mechanisms Underlying Aberrant Glycosylation of MUC1 Mucin in Breast Cancer Cells Inka Brockhausen, Jimao Yang, Joy Burchell, European Journal of Biochemistry	1995	347

Page 1